Arielle Stanford, MD

Overview

Arielle Stanford holds the position of Vice President Clinical and Medical Sciences at Ovid Therapeutics[1][3]. Stanford brings over 20 years of CNS clinical trial experience in pharmaceutical and academic settings across discovery through late-stage clinical development[2]. Stanford is board certified in psychiatry with over 15 years of clinical practice[2] and has expertise in schizophrenia and mood disorders[2]. Stanford's education includes a ScB in Neuroscience from Brown University[11], an MD from Washington University in St. Louis[12], and psychiatry residency and clinical research fellowship training in schizophrenia from Columbia University Vagelos College of Physicians and Surgeons[13]. Prior to joining Ovid Therapeutics, Stanford held positions at Bristol Myers Squibb in neuroscience clinical development[4][5][6], Alkermes in translational medicine and psychiatry[8][9][10], and MapLight Therapeutics as Senior Medical Director[7].

Career history

1. Vice President Clinical and Medical SciencesJul 2026 to presentOvid Therapeutics
2. Clinical Development Lead, Neuroscience2024 to Dec 2025Bristol Myers Squibb
3. Senior CTP II, Late Stage Development2024 to 2024Bristol Myers Squibb
4. Senior Director, Early Clinical Development, NeuroscienceJun 2023 to 2024Bristol Myers Squibb
5. MTSenior Medical Director2022 to 2022MapLight Therapeutics, Inc.
6. AMedical Director, Experimental Medicine, Translational Medicine2021 to 2022Alkermes
7. AClinical Lead, Translational Medicine CNS Team2019 to 2021Alkermes
8. AMedical Director, Psychiatry, Clinical Development2016 to 2021Alkermes

Education

1. ScB, NeuroscienceBrown University
2. WUMD, MedicineWashington University in St. Louis
3. CUPsychiatry Residency and Clinical Research Fellowship Training , SchizophreniaColumbia University Vagelos College of Physicians and Surgeons